BackY-Mabs Therapeutics Overview

Y-Mabs Therapeutics Total Liabilities

Track Y-Mabs Therapeutics's total liabilities ($30M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$29.72M
↓ 38.98% YoYΔ $-18.98M vs prior year quarter

Peer trimmed avg / median

Loading

Y-Mabs Therapeutics Total Liabilities History

Loading

Y-Mabs Therapeutics vs. peers: Total Liabilities Comparison

Loading

Y-Mabs Therapeutics Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Y-Mabs Therapeutics (YMAB) FAQ

The latest total liabilities for YMAB is $30M as of June 2025. That compares with $49M in the prior-year period — down 39.0% year over year. Investors often review this figure alongside Y-Mabs Therapeutics's historical trend and sector peers before judging valuation or financial health.

Over the past year, YMAB's total liabilities moved from $49M to $30M — a 39.0% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Y-Mabs Therapeutics's operating scale or balance-sheet position.

A total liabilities figure of $30M for YMAB is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting YMAB's total liabilities ($30M), review year-over-year change from $49M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Y-Mabs Therapeutics's total liabilities against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.